A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Therapeutic Effect and Safety of LPTAT in Children With Myopia
Latest Information Update: 02 Mar 2023
At a glance
- Drugs Atropine (Primary)
- Indications Myopia
- Focus Therapeutic Use
- Acronyms STAMP
- Sponsors LitePharmTech
- 02 Mar 2023 New trial record